Text this: Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Phase III Trial

 __   __     ___       _____    ______    _  _   
 \ \\/ //   / _ \\    / ___//  /_   _//  | \| || 
  \   //   / //\ \\   \___ \\   -| ||-   |  ' || 
  / . \\  |  ___  ||  /    //   _| ||_   | .  || 
 /_//\_\\ |_||  |_|| /____//   /_____//  |_|\_|| 
 `-`  --` `-`   `-` `-----`    `-----`   `-` -`